SANTA CLARA, Calif., Jan. 4 /PRNewswire-FirstCall/ -- XenoPort, Inc. announced today that it will provide access via the world wide web to its presentation at the JPMorgan 24th Annual Healthcare Conference. The live presentation will occur at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) on Thursday, January 12, 2006. A replay of the presentation will also be available.
To access the live presentation via the web, please go to www.XenoPort.com and click on the link provided under the JPMorgan Conference heading. Upon connecting to the conference website link, select the 24th Annual JPMorgan Healthcare Conference. You will then be prompted to register for the webcast. Upon registering, the conference “Welcome Page” will appear. Click on the “Live Webcast” link, and then click on XenoPort, Inc. Please connect to the website at least 15 minutes prior to the live presentation to ensure adequate time for any software downloads that may be necessary to listen to the webcast.
A replay of the webcast can be accessed for a minimum of one week and will be available approximately 24 hours after the live presentation.
About XenoPort
XenoPort, Inc. is a biopharmaceutical company focused on developing a portfolio of internally discovered product candidates that utilize the body’s natural nutrient transport mechanisms to improve the therapeutic benefits of existing drugs. XenoPort’s most advanced product candidate, XP13512, has successfully completed a Phase 2b clinical trial for the treatment of restless legs syndrome, or RLS, and a Phase 2a clinical trial for the management of post-herpetic neuralgia. XenoPort has also completed an initial Phase 1 clinical trial of XP19986, a Transported Prodrug of R-baclofen. This trial demonstrated that XP19986 was suitable for twice-a-day dosing and was well tolerated with few adverse events at the doses tested. XenoPort has commenced additional studies of XP19986, including a Phase 2a clinical trial in gastroesophageal reflux disease, or GERD, patients.
To learn more about XenoPort, please visit the web site at www.XenoPort.com.
NOTE: XenoPort is a registered U.S. trademark.
Source code: XPNT2G
XenoPort, Inc.
CONTACT: Jackie Cossmon, +1-408-616-7220, or ir@XenoPort.com
Web site: http://www.xenoport.com/
